Should You Buy Pfizer Stock After An Upbeat Q2?

This article was originally published on Nasdaq

Pfizer stock (NYSE: PFE) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates. However, PFE stock has seen a fall of around 5% in a week as the company didn’t raise its full-year outlook, and there are rising conc

Responses